Literature DB >> 17868808

Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality.

James K Min1, Leslee J Shaw, Richard B Devereux, Peter M Okin, Jonathan W Weinsaft, Donald J Russo, Nicholas J Lippolis, Daniel S Berman, Tracy Q Callister.   

Abstract

OBJECTIVES: The purpose of this study was to examine the association of all-cause death with the coronary computed tomographic angiography (CCTA)-defined extent and severity of coronary artery disease (CAD).
BACKGROUND: The prognostic value of identifying CAD by CCTA remains undefined.
METHODS: We examined a single-center consecutive cohort of 1,127 patients > or =45 years old with chest symptoms. Stenosis by CCTA was scored as minimal (<30%), mild (30% to 49%), moderate (50% to 69%), or severe (> or =70%) for each coronary artery. Plaque was assessed in 3 ways: 1) moderate or obstructive plaque; 2) CCTA score modified from Duke coronary artery score; and 3) simple clinical scores grading plaque extent and distribution. A 15.3 +/- 3.9-month follow-up of all-cause death was assessed using Cox proportional hazards models adjusted for pretest CAD likelihood and risk factors. Deaths were verified by the Social Security Death Index.
RESULTS: The CCTA predictors of death included proximal left anterior descending artery stenosis and number of vessels with > or =50% and > or =70% stenosis (all p < 0.0001). A modified Duke CAD index, an angiographic score integrating proximal CAD, plaque extent, and left main (LM) disease, improved risk stratification (p < 0.0001). Patients with <50% stenosis had the highest survival at 99.7%. Survival worsened with higher-risk Duke scores, ranging from 96% survival for 1 stenosis > or =70% or 2 stenoses > or =50% (p = 0.013) to 85% survival for > or =50% LM artery stenosis (p < 0.0001). Clinical scores measuring plaque burden and distribution predicted 5% to 6% higher absolute death rate (6.6% vs. 1.6% and 8.4% vs. 2.5%; p = 0.05 for both).
CONCLUSIONS: In patients with chest pain, CCTA identifies increased risk for all-cause death. Importantly, a negative CCTA portends an extremely low risk for death.

Entities:  

Mesh:

Year:  2007        PMID: 17868808     DOI: 10.1016/j.jacc.2007.03.067

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  274 in total

1.  Prognostic value of CT coronary angiography: focus on obstructive vs. nonobstructive disease and on the presence of left main disease.

Authors:  E Maffei; S Seitun; C Martini; A Aldrovandi; T Arcadi; A Clemente; G Messalli; R Malagò; A Weustink; N Mollet; K Nieman; D Ardissino; P de Feyter; G Krestin; F Cademartiri
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

Review 2.  Assessment of coronary heart disease by CT angiography: current and evolving applications.

Authors:  Abhishek Sharma; Armin Arbab-Zadeh
Journal:  J Nucl Cardiol       Date:  2012-08       Impact factor: 5.952

3.  Prognostic value of cardiovascular CT: is coronary artery calcium screening enough? The added value of CCTA.

Authors:  Erick Alexanderson; Nadia Canseco-León; Fernando Iñarra; Aloha Meave; Damini Dey
Journal:  J Nucl Cardiol       Date:  2012-04-04       Impact factor: 5.952

4.  Does the location of perfusion defects matter? An old question with a new answer.

Authors:  Mouaz H Al-Mallah; Waqas Qureshi
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

5.  Clinical indications for cardiac computed tomography. From the Working Group of the Cardiac Radiology Section of the Italian Society of Medical Radiology (SIRM).

Authors:  E di Cesare; I Carbone; A Carriero; M Centonze; F De Cobelli; R De Rosa; P Di Renzi; A Esposito; R Faletti; R Fattori; M Francone; A Giovagnoni; L La Grutta; G Ligabue; L Lovato; R Marano; M Midiri; L Natale; A Romagnoli; V Russo; F Sardanelli; F Cademartiri
Journal:  Radiol Med       Date:  2012-04-01       Impact factor: 3.469

6.  Interobserver agreement for the detection of atherosclerotic plaque in coronary CT angiography: comparison of two low-dose image acquisition protocols with standard retrospectively ECG-gated reconstruction.

Authors:  Annika Schuhbäck; Mohamed Marwan; Sören Gauss; Gerd Muschiol; Dieter Ropers; Christian Schneider; Michael Lell; Johannes Rixe; Christian Hamm; Werner G Daniel; Stephan Achenbach
Journal:  Eur Radiol       Date:  2012-03-27       Impact factor: 5.315

Review 7.  The role of non-invasive imaging in patients with suspected acute coronary syndrome.

Authors:  C Roobottom; G Mitchell; S Iyengar
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 8.  Integrated imaging of cardiac anatomy, physiology, and viability.

Authors:  James A Arrighi
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

9.  Clinical risk factors and atherosclerotic plaque extent to define risk for major events in patients without obstructive coronary artery disease: the long-term coronary computed tomography angiography CONFIRM registry.

Authors:  Alexander R van Rosendael; A Maxim Bax; Jeff M Smit; Inge J van den Hoogen; Xiaoyue Ma; Subhi Al'Aref; Stephan Achenbach; Mouaz H Al-Mallah; Daniele Andreini; Daniel S Berman; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Kavitha Chinnaiyan; Benjamin J W Chow; Ricardo C Cury; Augustin DeLago; Gudrun Feuchtner; Martin Hadamitzky; Joerg Hausleiter; Philipp A Kaufmann; Yong-Jin Kim; Jonathon A Leipsic; Erica Maffei; Hugo Marques; Pedro de Araújo Gonçalves; Gianluca Pontone; Gilbert L Raff; Ronen Rubinshtein; Todd C Villines; Heidi Gransar; Yao Lu; Jessica M Peña; Fay Y Lin; Leslee J Shaw; James K Min; Jeroen J Bax
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-05-01       Impact factor: 6.875

10.  Incremental prognostic value of coronary artery calcium score versus CT angiography among symptomatic patients without known coronary artery disease.

Authors:  Edward Hulten; Marcio Sommer Bittencourt; Brian Ghoshhajra; Daniel O'Leary; Mitalee P Christman; Michael J Blaha; Quynh Truong; Kyle Nelson; Philip Montana; Michael Steigner; Frank Rybicki; Jon Hainer; Thomas J Brady; Udo Hoffmann; Marcelo F Di Carli; Khurram Nasir; Suhny Abbara; Ron Blankstein
Journal:  Atherosclerosis       Date:  2014-01-08       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.